A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England.
Bateman
D N
DN
NPIS Edinburgh, Scottish Poisons Information Bureau, Royal Infirmary of Edinburgh, 51 Little France Crescent, EH16 4SA, Edinburgh, UK. Nick.bateman@luht.scot.nhs.uk
McElhatton
P R
PR
Dickinson
D
D
Wren
C
C
Matthews
J N S
JN
O'Keeffe
M
M
Thomas
S H L
SH
D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000009:adverse effects; D001724:Birth Weight; D016022:Case-Control Studies; D015331:Cohort Studies; D064420:Drug-Related Side Effects and Adverse Reactions; D004739:England / Q000453:epidemiology; D005260:Female; D006213:Hallucinogens / Q000009:adverse effects; D006345:Heart Septal Defects, Ventricular / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects; D008875:Middle Aged; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects; D016017:Odds Ratio; D011247:Pregnancy; D012307:Risk Factors
D000662:Amphetamines; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine